Suchergebnisse - "Smith, Patrick F"

PubPharm (14)

1

Modelling the interaction between danoprevir and mericitabine in the treatment of chronic HCV infection

enthalten in: Antiviral therapy | 2016

von Canini, L. | Guedj, J. | Chatterjee, A. | +3

2

Characterization of the transmembrane transport and absolute bioavailability of the HCV protease inhibitor danoprevir

enthalten in: Clinical pharmacokinetics | 2015

von Brennan, B. | Poirier, A. | Moreira, S. | +6

3

A pharmacokinetic/viral kinetic model to evaluate the treatment effectiveness of danoprevir against chronic HCV

enthalten in: Antiviral therapy | 2015

von Canini, L. | Chatterjee, A. | Guedj, J. | +4

4

Effect of ritonavir-boosted danoprevir, a potent hepatitis C virus protease inhibitor, on the pharmacokinetics of methadone in healthy subjects undergoing methadone maintenance therapy

enthalten in: Pharmacotherapy | 2014

von Moreira, S. | Morcos, P. | Navarro, M. | +3

5

Two-way interaction study between ritonavir boosted danoprevir, a potent HCV protease inhibitor, and ketoconazole in healthy subjects

enthalten in: International journal of clinical pharmacology and therapeutics | 2014

von Morcos, P. | Chang, L. | Navarro, M. | +4

6

Effect of meal and antisecretory agents on the pharmacokinetics of danoprevir/ritonavir in healthy volunteers

enthalten in: The Journal of pharmacy and pharmacology | 2014

von Morcos, P. | Moreira, S. | Navarro, M. | +4

7

A randomised study of the effect of danoprevir/ritonavir or ritonavir on substrates of cytochrome P450 (CYP) 3A and 2C9 in chronic hepatitis C patients using a drug cocktail

enthalten in: European journal of clinical pharmacology | 2013

von Morcos, P. | Chang, L. | Kulkarni, R. | +5

8

Pharmacokinetics of a three-way drug interaction between danoprevir, ritonavir and the organic anion transporting polypeptide (OATP) inhibitor ciclosporin

enthalten in: Clinical pharmacokinetics | 2013

von Brennan, B. | Moreira, S. | Morcos, P. | +5

9

Effect of IL28B genotype on early viral kinetics during interferon-free treatment of patients with chronic hepatitis C

enthalten in: Gastroenterology | 2012

von Chu, T. | Kulkarni, R. | Gane, E. | +12

CommentIn: Hepatology. 2012 Dec;56(6):2414-6. - PMID 23212777

10

Antiviral activity of danoprevir (ITMN-191/RG7227) in combination with pegylated interferon α-2a and ribavirin in patients with hepatitis C

enthalten in: The Journal of infectious diseases | 2011

von Forestier, N. | Larrey, D. | Marcellin, P. | +10